Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of seven studies at the European Congress...

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,London ,City Of ,United Kingdom ,Vienna ,Wien ,Austria ,Netherlands ,Odense ,Syddanmark ,Denmark ,Carolyn Horst ,Prnewswire Lunit ,Brandon Suh ,Radboud University Medical Center ,King College London ,Odense University Hospital ,Research Stage ,European Congress ,Lancet Digital Health ,Presents Seven Study Results ,Diverse Clinical ,College London ,Area Under ,Leeds Teaching Hospitals ,United Kingdom Leeds Teaching Hospitals ,Artificial Intelligence Tool ,Identifying Common Pathologies ,Chest Radiographs ,Chest Radiograph Evaluation ,Repurposed Use ,Commercially Available ,Clinical Oncology ,